However, PT-based serology suffers one important drawback: extensive use of acellular pertussis vaccines that deliver substantial amounts of PT complicates the serological diagnosis by elevating anti-PT IgG levels in vaccinated individuals for several years [2,3,4]. The gene discussed is F2; the disease is pertussis.